Overview

Latanoprost for the Treatment of Menière's Disease

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the dose regimen, efficacy and safety of latanoprost for the treatment of Menière's disease.
Phase:
Phase 2
Details
Lead Sponsor:
Synphora AB
Treatments:
Latanoprost